{"log_id": 244314863783684847, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0, "average": 0.99998, "min": 0.99998}, "location": {"width": 27, "top": 9, "height": 26, "left": 1100}, "words": "食"}, {"probability": {"variance": 0, "average": 0.999408, "min": 0.999408}, "location": {"width": 30, "top": 85, "height": 28, "left": 1102}, "words": "附"}, {"probability": {"variance": 0.000286, "average": 0.991532, "min": 0.953717}, "location": {"width": 126, "top": 148, "height": 29, "left": 283}, "words": "窦性心动过缓"}, {"probability": {"variance": 0.001222, "average": 0.980307, "min": 0.90148}, "location": {"width": 201, "top": 185, "height": 29, "left": 287}, "words": "已出现症状性心律失常"}, {"probability": {"variance": 0.000113, "average": 0.995687, "min": 0.940332}, "location": {"width": 600, "top": 212, "height": 45, "left": 285}, "words": "联合使用已知可导致QTc间期延长的药品(除了在禁忌中提到的药物)"}, {"probability": {"variance": 0.000543, "average": 0.991849, "min": 0.886938}, "location": {"width": 723, "top": 258, "height": 49, "left": 249}, "words": "电解质紊乱,在泊沙康唑治疗前和治疗过程中,必要时应对电解质紊乱,特别是钾离子"}, {"probability": {"variance": 2e-06, "average": 0.998838, "min": 0.994931}, "location": {"width": 320, "top": 315, "height": 38, "left": 211}, "words": "镁离子或钙离子水平进行监测和纠正"}, {"probability": {"variance": 0.000387, "average": 0.992737, "min": 0.879437}, "location": {"width": 743, "top": 339, "height": 49, "left": 250}, "words": "泊沙康唑是CYP3A4抑制剂,在其它通过CYP3A4代谢的药品治疗期间,只能在特殊情"}, {"probability": {"variance": 9.8e-05, "average": 0.996144, "min": 0.960508}, "location": {"width": 272, "top": 394, "height": 34, "left": 212}, "words": "况下使用(参见药物相互作用)"}, {"probability": {"variance": 7.6e-05, "average": 0.995055, "min": 0.977578}, "location": {"width": 102, "top": 447, "height": 26, "left": 253}, "words": "3、肝毒性"}, {"probability": {"variance": 1.8e-05, "average": 0.997258, "min": 0.9815}, "location": {"width": 742, "top": 462, "height": 50, "left": 255}, "words": "在临床试验中,出现了肝脏不良反应(例如轻度至中度丙氨酸氨基转移酶(ALT)、天"}, {"probability": {"variance": 8.4e-05, "average": 0.995777, "min": 0.947822}, "location": {"width": 780, "top": 502, "height": 50, "left": 218}, "words": "冬氨酸氨基转移酶(AST)、碱性磷酸酶、总胆红素水平升高和或临床肝炎)。肝功能检"}, {"probability": {"variance": 0.000253, "average": 0.995372, "min": 0.900796}, "location": {"width": 783, "top": 540, "height": 51, "left": 217}, "words": "查参数升高通常在停止治疗时可逆转,在某些情况下,在未暂停药物治疗时,这些试验结果"}, {"probability": {"variance": 6.9e-05, "average": 0.996392, "min": 0.958353}, "location": {"width": 771, "top": 579, "height": 51, "left": 219}, "words": "可恢复正常,极少需要停药。在罕见情况下,患有严重基础疾病(例如血液系统恶性肿瘤"}, {"probability": {"variance": 6.9e-05, "average": 0.996624, "min": 0.960701}, "location": {"width": 782, "top": 617, "height": 53, "left": 219}, "words": "的患者在泊沙康唑治疗期间出现更重度的肝脏不良反应,包括胆汁淤积或肝功能衰竭,甚至"}, {"probability": {"variance": 0.000267, "average": 0.991882, "min": 0.908833}, "location": {"width": 774, "top": 660, "height": 48, "left": 221}, "words": "死亡。这些重度肝脏不良反应主要见于一项临床试验中接受每日800mg(400mg,每日2次"}, {"probability": {"variance": 1.2e-05, "average": 0.997614, "min": 0.984723}, "location": {"width": 308, "top": 711, "height": 40, "left": 223}, "words": "或200mg,每日4次)治疗的受试者"}, {"probability": {"variance": 0.000242, "average": 0.995037, "min": 0.907503}, "location": {"width": 737, "top": 738, "height": 50, "left": 264}, "words": "在开始泊沙康唑治疗和治疗期间,必须对肝功能检查进行评估。对于泊沙康唑治疗出现"}, {"probability": {"variance": 0.000257, "average": 0.996022, "min": 0.896434}, "location": {"width": 780, "top": 779, "height": 49, "left": 224}, "words": "肝功能检查异常的患者,必须对发生更重度的肝损伤进行监测。患者管理必须包括肝功能实"}, {"probability": {"variance": 0.003583, "average": 0.97846, "min": 0.690942}, "location": {"width": 767, "top": 819, "height": 49, "left": 225}, "words": "验室评估(尤其是肝功能检查和胆红素)。如果临床体征和症状符合肝病,并且与沙康"}, {"probability": {"variance": 0, "average": 0.999717, "min": 0.999512}, "location": {"width": 108, "top": 851, "height": 33, "left": 929}, "words": "国药"}, {"probability": {"variance": 2.9e-05, "average": 0.997143, "min": 0.981183}, "location": {"width": 260, "top": 871, "height": 35, "left": 228}, "words": "相关,必须停止泊沙康唑治疗"}, {"probability": {"variance": 0.000326, "average": 0.986824, "min": 0.937547}, "location": {"width": 175, "top": 920, "height": 32, "left": 266}, "words": "4、与咪达唑仑联用"}, {"probability": {"variance": 0.003848, "average": 0.979075, "min": 0.646399}, "location": {"width": 734, "top": 951, "height": 49, "left": 268}, "words": "本品与咪达唑仑联合用药会导致咪达唑仑血浆浓度约升高5倍。而咪达唑仑血浆浓度升"}, {"probability": {"variance": 0.004707, "average": 0.975056, "min": 0.674678}, "location": {"width": 754, "top": 998, "height": 46, "left": 238}, "words": "高则会增强并且延长催眠和镇静作用。必须密切监测治疗患者是否发生咪达唑色血浆浓度"}, {"probability": {"variance": 0.001042, "average": 0.99043, "min": 0.820306}, "location": {"width": 630, "top": 1046, "height": 44, "left": 232}, "words": "高导致的不良反应,并且必须备有苯二氮卓受体拮抗剂用于逆转这些反应"}, {"probability": {"variance": 5e-06, "average": 0.998553, "min": 0.994805}, "location": {"width": 75, "top": 1103, "height": 26, "left": 272}, "words": "5、其他"}, {"probability": {"variance": 0.024729, "average": 0.835456, "min": 0.678199}, "location": {"width": 134, "top": 1071, "height": 51, "left": 915}, "words": "菲医"}, {"probability": {"variance": 0, "average": 0.999827, "min": 0.999603}, "location": {"width": 80, "top": 1150, "height": 23, "left": 275}, "words": "过敏反应"}, {"probability": {"variance": 0.000379, "average": 0.993853, "min": 0.881942}, "location": {"width": 736, "top": 1169, "height": 43, "left": 277}, "words": "尚无泊沙康唑与其它唑类抗真菌药物有交叉过敏的相关信息。在对其它唑类药物过敏的"}, {"probability": {"variance": 2.3e-05, "average": 0.996535, "min": 0.981097}, "location": {"width": 377, "top": 1217, "height": 36, "left": 237}, "words": "患者使用泊沙康唑时,应注意观察过敏情况"}, {"probability": {"variance": 0.000661, "average": 0.987825, "min": 0.93032}, "location": {"width": 120, "top": 1273, "height": 26, "left": 277}, "words": "胃肠功能紊乱"}, {"probability": {"variance": 4e-05, "average": 0.997011, "min": 0.966002}, "location": {"width": 739, "top": 1296, "height": 40, "left": 278}, "words": "有关重度胃肠功能紊乱(如重度腹泻)患者中的药代动力学数据有限。在重度腹泻或呕"}, {"probability": {"variance": 8e-06, "average": 0.998257, "min": 0.987687}, "location": {"width": 418, "top": 1339, "height": 37, "left": 238}, "words": "吐患者中,必须对突破性真菌感染进行密切监测"}, {"probability": {"variance": 0.005166, "average": 0.981463, "min": 0.556693}, "location": {"width": 739, "top": 1382, "height": 42, "left": 280}, "words": "利福霉素抗菌药物(利福平、利福布汀)、特定的抗惊厥剂(苯妥英、卡马西平、苯"}, {"probability": {"variance": 0.002978, "average": 0.977477, "min": 0.755531}, "location": {"width": 357, "top": 1435, "height": 32, "left": 242}, "words": "巴比妥、扑米酮)、依法韦仑和西咪替丁"}], "language": 3}